Calcineurin Inhibitors For Eczema. Cancer risk associated with topical calcineurin inhibitors (tcis) remains unclear. Topical calcineurin inhibitors are treatments used to control atopic dermatitis, which is the most common form of chronic eczema.
Topical calcineurin inhibitors for eczema another category of topical treatments consists of the calcineurin inhibitors, tacrolimus and pimecrolimus. Two of these medicines are approved to treat atopic dermatitis: Topical calcineurin inhibitors may be helpful.